RNA Therapeutics Core launches at Mass General Brigham to boost circular RNA research

The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource to advance the use of RNA technologies within and beyond the Mass General Brigham research ecosystem.

Sunstone Therapies Announces Expansion of Innovative Dyad Study – Psychedelic Alpha

Sunstone Therapies Announces Expansion of Innovative Dyad Study Expansion of Phase 2 pilot trial to assess MDMA-assisted therapy for adjustment disorder in dyads of patients

October 3, 2023

AI model can accurately screen for post-traumatic stress disorder after childbirth

A generative artificial intelligence (AI) model that can analyze the narrative accounts of women who have undergone recent childbirth has shown the ability to accurately

April 13, 2024

FDA grants accelerated approval for PTC’s AADC deficiency gene therapy

AADC deficiency is a genetic disorder that severely impairs motor function by preventing dopamine synthesis. Credit: Gatot Adri via Shutterstock. The US Food and Drug

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.